Financings in Brief: HemaCare Corp.
This article was originally published in The Gray Sheet
HemaCare Corp.: Blood products and services firm nets $1.2 mil. from recently completed private placement of 1.2 mil. shares of common stock. "The use of proceeds include enabling the company to maintain listing compliance with the Nasdaq SmallCap Market," the firm states...
You may also be interested in...
Abbott reported almost 28% revenue growth in the fourth quarter led by the exploding demand for COVID-19 tests and continued success of its FreeStyle Libre continuous glucose monitor.
While representing a smaller population, the ACTIVATE-T trial targeted patients seen as having greater unmet need.
As a freshman member on the US House Energy and Commerce Committee, former St. Jude Medical exec Rep. Angie Craig can help shape future health care, cybersecurity bills.